NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

Who cares. The trial is over. The 'long trial' is complete. What are we looking at now? NWBO and DCVax-L has 5 year OS data for nGBM and rGBM showing statistically/clinically significant improvement over the SoC. Of the prior 886 GBM trials, NONE have shown successful 5 year OS for nGBM and rGBM.

These trials are not quick. These trials are not cheap. The vast majority have failed. None have shown a 5 year OS increase. NWBO and DCVax-L did what no other trial has done.

We are in the year 2022. The trial is done. It is a success. The next step is approvals.

Approvals are coming.